Pfizer to Buy Seagen in $43 Billion Deal
By Colin Kellaher Pfizer Inc on Monday said it has agreed to buy biotech company Seagen Inc for $43 billion in a move to bolster its cancer program. The New York-based drugmaker said it would pay $229…
Recover your password.
A password will be e-mailed to you.